WO2005070863A1 - An athermal process for the concentration of garcinia extract - Google Patents

An athermal process for the concentration of garcinia extract Download PDF

Info

Publication number
WO2005070863A1
WO2005070863A1 PCT/IB2003/006105 IB0306105W WO2005070863A1 WO 2005070863 A1 WO2005070863 A1 WO 2005070863A1 IB 0306105 W IB0306105 W IB 0306105W WO 2005070863 A1 WO2005070863 A1 WO 2005070863A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
membrane
garcinia
osmotic
hca
Prior art date
Application number
PCT/IB2003/006105
Other languages
French (fr)
Inventor
Chinnaswamy Anandha Ramakrishnan
Naveen Nagaraj
Guddadarangavvanahally Krishnareddy Jayaprakasha
Bhabani Sankar Jena
Mandyam Chakravarathy Varadaraj
Karumanchi Sreesaila Mallikarjuna Srinivasa Raghavarao
Original Assignee
Council Of Scientific And Industrial Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Of Scientific And Industrial Research filed Critical Council Of Scientific And Industrial Research
Priority to JP2005514334A priority Critical patent/JP4499664B2/en
Priority to PCT/IB2003/006105 priority patent/WO2005070863A1/en
Priority to AU2003288610A priority patent/AU2003288610B2/en
Publication of WO2005070863A1 publication Critical patent/WO2005070863A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/47Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Definitions

  • the present invention relates to an athermal process for the concentration of Garcinia extract.
  • the present invention particularly relates to a process of obtaining concentrated Garcinia extract by using osmotic membrane distillation (OMD).
  • OMD osmotic membrane distillation
  • HCA Hexadroxcitic acid
  • Allison et al. (Crit.Rev.Food Sci.Nutr. 2001, 41,1-28) has reviewed the use of HCA as one of the alternative treatments for weight loss.
  • the derivatives of HCA have been incorporated into many pharmaceutical preparations in combination with other ingredients for the purpose of enhancing weight loss, cardioprotection, correcting the conditions of lipid abnormalities and endurance(Jena et al., 2002, J. Agric. Food Chemistry, 50,10-22). So far HCA has been found in the fruits of certain species of Garcinia, which includes G. cambogia, G. indica, G.atroviridis and G.
  • Garcinia (Family: Guttiferae) is a large genus of polygamous trees or shrubs, distributed in the tropical Asia, Africa and Polynesia. It consists of 180 species, out of which about 30 species are found in India. G. pedunculata and G. cowa are grown in Northeastern parts of India and Andaman Islands. In Assam G. cowa is often cultivated in homesteads for its acid fruits (The Wealth of India, 1956). The fruits from both the species of Garcinia are not palatable due to their strong acid taste. In Assam the sun dried slices of the fruits are used for culinary purposes and as folk medicine.
  • Balasubramamanvam (US patent # 656314, 1996 ). This process involves water extraction, followed by passing through ion exchange resins and decolorisation by using activated charcoal and finally concentration by using vacuum evaporation.
  • the main drawback of this method is the thermal process and also it involves too many unit operations for obtaining the final product.
  • Garcinia fruit was reported. It involves the extraction of Garcinia fruit using alkyl alcohol, the extract was treated with potassium hydroxide and refluxed to form potassium hydroxycitrate precipitate.
  • the main drawback of this method is the potassium salt is hygroscopic. Further, HCA is not available in natural state, limiting its bioavailability and versatile applicability for pharmaceutical purposes.
  • the main object of the present invention is to develop a process for the concentrated
  • Another object of present invention is to develop a non-thermal process for the concentration of Garcinia extract.
  • Still another object of the present invention is to develop a process for the concentrating of
  • Yet another object of present invention is to provide a simple single step and efficient economical process for the concentration of HCA, wher it is present in its native form.
  • the present invention provides an athermal process for the concentrating of
  • Garcinia extract which comprises (a) collecting the dried fruit rinds may be effected from the species of Garcinia. (b) cutting the rinds of G pedunculata /G.cowa manually to a size of 3x9mm to 6x14mm. (c) extracting may be effected with de-ionized water at a volume ratio of 1 :4 for a period of 15-35 min at 110-130°C. (d) filtering the above extract may be effected by filter cloth. (e) concentrating the HCA by osmotic membrane distillation (OMD) in a co- current flat membrane module. (f) placing a hydrophobic membrane between two steel frames SS316 of the module with suitable spaces.
  • OMD osmotic membrane distillation
  • the HCA concentration may be obtained from the aqueous extract of G. pedunculata and G.cowa.
  • concentrated Garcinia extract may be obtained by using an athermal membrane process namely, Osmotic membrane distillation (OMD) at ambient temperature (25 ⁇ 1°C) and pressure (latm).
  • OMD Osmotic membrane distillation
  • the HCA content of the concentrated Garcinia extract is in the range of 33-37% estimated by HPLC method.
  • the Garcinia extract was concentrated by a simple single step process where the HCA content was increased from 4-6 fold and HCA is present in the native form (not as derivative) with out formation of lactone, increasing it commercial and nutritive values. .
  • rinds of G. pedunculata / G.coxva were cut into small pieces and extracted with de-ionized water.
  • the above extract was filtered through filter cloth.
  • the membrane module consisted of two steel frames SS316 between which a hydrophobic membrane was placed. The entire filtrate was circulated on the one side of the OMD membrane and on the other side, an osmotic agent (OA) was circulated using a multi-stage peristaltic pump. After desired time the extract was concentrated in the feed tank.
  • OA osmotic agent
  • the purity of the preparation was analyzed by HPLC as described by Jayaprakasha, G.K. and Sakariah, K.K. (J. Liquid Chromatography & Related Technologies, 23, 915-923, 2000).
  • Concentrated hydroxycitric acid (0.1 g) was dissolved in water and made up to 100ml with water and filtered.
  • the high performance liquid chromatographic system consisted of a Hewlett Packard HPLC model HP 1100 Series (Hewlett-Packard, CA, USA), fitted with a Waters ⁇ -BondapackTM (Waters Corporation, Milford, MA, USA) C, 8 column (250 x 4.6 mm I.D).
  • the injection system (Rheodyne) used was 20 ⁇ l sample loop.
  • Detection was done by a HP 1 100 series variable wavelength detector at wavelength of 210 nm. The elution was carried out with 8 mM sulphuric acid and flow rate was 1.0 ml/min under isocratic condition. A known volume (lO ⁇ l) of the samples was injected on to the HPLC and the concentration of HCA was obtained directly from the peak area and by application of the dilution factor. The HCA concentration of the sample was expressed as g/100 g of sample. The purity of hydroxycitric acid was 33-35 % (w/w). The important aspects of the invention are:
  • Concentrated Garcinia extract is obtained by athermal membrane process.
  • Example-1 is given by way of illustration of the present invention and should not be construed to limit the scope of the present invention.
  • Example-2 Fruit rinds of G. cowa in lOOOg quantity were cut into small pieces and extracted with 3 liters of de-ionized water for a period of 30 min at 130 psi using autoclaving. The extract was filtered through filter cloth. The extract was taken and subjected to concentration by osmotic membrane distillation in a co-current flat membrane module using micro porous hydrophobic polypropylene membrane of 0.05 ⁇ m at a flow rate of 130 ml/min. The module was operated in co-current mode using saturated calcium chloride as osmotic agent.
  • This concentrated Garcinia extract is in its native form without being any of its derivatives like sodium, potassium and calcium salts. Hence it will have better bioavailability.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to an athermal process of obtaining concentrated Garcinia extract by using osmotic membrane distillation (OMD).

Description

AN ATHERMAL PROCESS FOR THE CONCENTRATION OF GARCINIA EXTRACT Field of the invention:
The present invention relates to an athermal process for the concentration of Garcinia extract. The present invention particularly relates to a process of obtaining concentrated Garcinia extract by using osmotic membrane distillation (OMD). Background of the invention:
As dietary supplement, (-)-Hydroxcitic acid (HCA) is an effective agent to any weight management program. Allison et al. (Crit.Rev.Food Sci.Nutr. 2001, 41,1-28) has reviewed the use of HCA as one of the alternative treatments for weight loss. The derivatives of HCA have been incorporated into many pharmaceutical preparations in combination with other ingredients for the purpose of enhancing weight loss, cardioprotection, correcting the conditions of lipid abnormalities and endurance(Jena et al., 2002, J. Agric. Food Chemistry, 50,10-22). So far HCA has been found in the fruits of certain species of Garcinia, which includes G. cambogia, G. indica, G.atroviridis and G. cowa (Lewis, Y.S. 1969, Methods in enzymology, 13, 613-623; Jena et al., 2002, J. Agric. Food Chemistry, 50,10-22). The chemistry and biochemistry of HCA has been discussed recently (Jena et al., 2002, J. Agric. Food Chemistry, 50,10-22). During extensive animal studies, HCA has been proven to effectively curb appetite, suppress food intake, increase the rates of hepatic glycogen synthesis, reduce fatty acid synthesis and lipogenesis and decrease body-weight gain.
Garcinia (Family: Guttiferae) is a large genus of polygamous trees or shrubs, distributed in the tropical Asia, Africa and Polynesia. It consists of 180 species, out of which about 30 species are found in India. G. pedunculata and G. cowa are grown in Northeastern parts of India and Andaman Islands. In Assam G. cowa is often cultivated in homesteads for its acid fruits (The Wealth of India, 1956). The fruits from both the species of Garcinia are not palatable due to their strong acid taste. In Assam the sun dried slices of the fruits are used for culinary purposes and as folk medicine. Reference may be made to the commercial samples of Garcinia cambogia extracts, where the HCA is present as its calcium salt (Sawada, et al, 1997, Nihon yukagaka kaishi, vol, 1467- 1474). But the excess calcium reduces the solubility and subsequently bioavailability when it is compared to the liquid extract. Another reference may be made to the Ashok kumar., Ravindranath, B., and
Balasubramamanvam (US patent # 656314, 1996 ). This process involves water extraction, followed by passing through ion exchange resins and decolorisation by using activated charcoal and finally concentration by using vacuum evaporation. The main drawback of this method is the thermal process and also it involves too many unit operations for obtaining the final product.
Reference may be made to Majeed et al. (Majeed, M., Badmaev, V and Rajendran, R. US
Patent. 5783603, 1998), wherein the preparation of potassium hydroxycitrate from
Garcinia fruit was reported. It involves the extraction of Garcinia fruit using alkyl alcohol, the extract was treated with potassium hydroxide and refluxed to form potassium hydroxycitrate precipitate. The main drawback of this method is the potassium salt is hygroscopic. Further, HCA is not available in natural state, limiting its bioavailability and versatile applicability for pharmaceutical purposes.
It may be noted that all these references are mentioned above HCA derivatives preparations. But, there is no report on non-thermal process for concentrating of HCA and also in its native (not as derivatives) form.
Objects of the invention:
The main object of the present invention is to develop a process for the concentrated
Garcinia extract from G. pedunculata / G.cowa in liquid form. Another object of present invention is to develop a non-thermal process for the concentration of Garcinia extract.
Still another object of the present invention is to develop a process for the concentrating of
Garcinia extract using osmotic membrane distillation (OMD).
Yet another object of present invention is to provide a simple single step and efficient economical process for the concentration of HCA, wher it is present in its native form.
Detailed description of the invention:
Accordingly, the present invention provides an athermal process for the concentrating of
Garcinia extract, which comprises (a) collecting the dried fruit rinds may be effected from the species of Garcinia. (b) cutting the rinds of G pedunculata /G.cowa manually to a size of 3x9mm to 6x14mm. (c) extracting may be effected with de-ionized water at a volume ratio of 1 :4 for a period of 15-35 min at 110-130°C. (d) filtering the above extract may be effected by filter cloth. (e) concentrating the HCA by osmotic membrane distillation (OMD) in a co- current flat membrane module. (f) placing a hydrophobic membrane between two steel frames SS316 of the module with suitable spaces. (g) circulating the extract at a flow rate of 100-150 ml/min on the one side of the membrane using a multi-stage peristaltic pump. (h) hydrophobic membrane osmotic agent (OA) on the other side of the membrane using a multi-stage peristaltic pump. (i) carrying out OMD for about 4-6 hrs till the extract was concentrated in the feed tank. In an embodiment of the present invention, the HCA concentration may be obtained from the aqueous extract of G. pedunculata and G.cowa. In an another embodiment of the present invention, concentrated Garcinia extract may be obtained by using an athermal membrane process namely, Osmotic membrane distillation (OMD) at ambient temperature (25± 1°C) and pressure (latm).
Still another embodiment of present invention, the HCA content of the concentrated Garcinia extract is in the range of 33-37% estimated by HPLC method. Yet in another embodiment of present invention the Garcinia extract was concentrated by a simple single step process where the HCA content was increased from 4-6 fold and HCA is present in the native form (not as derivative) with out formation of lactone, increasing it commercial and nutritive values. .
In the present invention, rinds of G. pedunculata / G.coxva were cut into small pieces and extracted with de-ionized water. The above extract was filtered through filter cloth. Concentrating the HCA by osmotic membrane distillation in a co-current flat membrane module. The membrane module consisted of two steel frames SS316 between which a hydrophobic membrane was placed. The entire filtrate was circulated on the one side of the OMD membrane and on the other side, an osmotic agent (OA) was circulated using a multi-stage peristaltic pump. After desired time the extract was concentrated in the feed tank.
The purity of the preparation was analyzed by HPLC as described by Jayaprakasha, G.K. and Sakariah, K.K. (J. Liquid Chromatography & Related Technologies, 23, 915-923, 2000). Concentrated hydroxycitric acid (0.1 g) was dissolved in water and made up to 100ml with water and filtered. The high performance liquid chromatographic system consisted of a Hewlett Packard HPLC model HP 1100 Series (Hewlett-Packard, CA, USA), fitted with a Waters μ-Bondapack™ (Waters Corporation, Milford, MA, USA) C,8 column (250 x 4.6 mm I.D). The injection system (Rheodyne) used was 20 μl sample loop. Detection was done by a HP 1 100 series variable wavelength detector at wavelength of 210 nm. The elution was carried out with 8 mM sulphuric acid and flow rate was 1.0 ml/min under isocratic condition. A known volume (lOμl) of the samples was injected on to the HPLC and the concentration of HCA was obtained directly from the peak area and by application of the dilution factor. The HCA concentration of the sample was expressed as g/100 g of sample. The purity of hydroxycitric acid was 33-35 % (w/w). The important aspects of the invention are:
1. Concentrated Garcinia extract is obtained by athermal membrane process.
2. This is a single step process for obtaining the concentrated Garcinia extract.
3. In the present process there is no phase change. 4. This process is operated at ambient temperature and pressure so that no thermal damage of the product. 5. HCA content was increased from 4-6 fold.
4. There is no lactone formation during this process.
The following examples are given by way of illustration of the present invention and should not be construed to limit the scope of the present invention. Example-1
Fruit rinds of G. pedunculata in 500g quantity were cut into small pieces and extracted with 1.5 liters of de-ionized water for a period of 20 min at 120°C. The above extract was filtered through filter cloth. The extract was taken and subjected to concentration by osmotic membrane distillation in a co-current flat membrane module using micro porous hydrophobic polypropylene membrane of 0.05μm at a flow rate of 100 ml/min. The module was operated in co-current mode using saturated calcium chloride as osmotic agent. The concentration was carried out till the volume of the extract was reduced to 1/511 of the original volume. The concentration of HCA had increased from 6 to 62°Brix. The HCA content was determined by HPLC method and the acid was found to be 33.58% from an initial content of 5.09 %. (6 fold enhancement). Example-2 Fruit rinds of G. cowa in lOOOg quantity were cut into small pieces and extracted with 3 liters of de-ionized water for a period of 30 min at 130 psi using autoclaving. The extract was filtered through filter cloth. The extract was taken and subjected to concentration by osmotic membrane distillation in a co-current flat membrane module using micro porous hydrophobic polypropylene membrane of 0.05μιm at a flow rate of 130 ml/min. The module was operated in co-current mode using saturated calcium chloride as osmotic agent. The concentration was carried out till the volume of the extract was reduced to l/5th of the original volume. The concentration of HCA had increased from 6 to 62°Brix: The HCA content was determined by HPLC method and the acid was found to be 35.5% from an initial content of 6%. (7 fold enhancement). Example-3
Fruit rinds of G. pedunculata in 1 OOgm quantity were cut into small pieces and extracting with 1 liter of de-ionized water for a period of 50 min at 120°C using autoclaving. The extract was filtered through filter cloth. The extract was taken and subjected to concentration by osmotic membrane distillation in a co-current flat membrane module using micro porous hydrophobic polypropylene membrane of 0.05μm at a flow rate of 150 ml/min. The module was operated in co-current mode using saturated calcium chloride as osmotic agent. The concentration was carried out till the volume of the extract was reduced to 1/511 of the original volume. The concentration of HCA had increased from 6 to 62°Brix. The HCA content was determined by HPLC method and the acid was found to be 34.5% from an initial content of 5%. (6 fold enhancement). The main advantages of the present invention are
1. This is a simple and single step process for obtaining the concentrated free HCA.
2. This concentrated Garcinia extract is in its native form without being any of its derivatives like sodium, potassium and calcium salts. Hence it will have better bioavailability.
3. This product does not undergo any theπnal damage since the process is athermal, therby the product is suitable for food/therapeutic applications.
4. This process is simpler and easy to scale-up.

Claims

We claim:
1. An athermal process for the concentrating Garcinia extract, which comprises a) collecting and cutting dried rinds of a fruit selected from Garcinia sp, G. pedunculata and G.cowa, b) extracting the cut rinds with de-ionized water at a volume ratio of 1 :4 for a period of 20-30 min at 115°C -130°C to obtain an extract, c) filtering the extract to obtain a particle free extract, and d) subjecting the particle free extract to osmotic membrane distillation in a co- current mode in the presence of an osmotic agent until the extract reduced to 1 /5th of its original volume.
2. A process as claimed in claim 1 further comprising the step of obtaining hydrocitric acid from the concentrated extract of step (d).
3. A process as claimed in claim 1 wherein a hydrophobic membrane is placed between two steel frames SS316 of the module with suitable spaces.
4. A process as claimed in claim 1 wherein the extract is circulated at a flow rate of 100- 150 ml/min on one side of the membrane using a multi-stage peristaltic pump.
5. A process as claimed in claim 1 wherein a hydrophobic membrane osmotic agent (OA) is placed on the other side of the membrane using a multi-stage peristaltic pump.
6. A process as claimed in claim 1 wherein the osmotic agent is saturated calcium chloride.
7. A process as claimed in claim 1 wherein the osmotic membrane distillation is carried out at ambient temperature of 25+ 1 °C and pressure of 1 atm.
8. A process as claimed in claim 1 wherein the osmotic membrane distillation is carried on for about 4-6 hrs till the extract was concentrated in the feed tank.
9. A process as claimed in claim 1 wherein the free hydrocitric acid content in the concentrate is in the range 33-35 % estimated by HPLC method.
10. A process as claimed in claim 1 wherein the hydrocitric acid content was increased from 4-6 fold and HCA is present in the native form (not as derivative) with out formation of lactone, increasing it commercial and nutritive values.
11. An athermal process for the concentration of Garcinia extract comprising the steps of: a) collecting the dried fruit rinds may be effected from the species of Garcinia b) cutting the rinds of G. pedunculata /G.cowa manually to a size of 3x9mm to 6x14mm c) extracting may be effected with de-ionized water at a volume ratio of 1:4 for a period of 15-35 min at 110-130°C. d) filtering the above extract may be effected by filter cloth e) concentrating the HCA by osmotic membrane distillation (OMD) in a co-current flat membrane module f) placing a hydrophobic membrane between two steel frames SS316 of the module with suitable spaces g) circulating the extract at a flow rate of 100-150 ml/min on the one side of the membrane using a multi-stage peristaltic pump h) hydrophobic membrane osmotic agent (OA) on the other side of the membrane using a multi-stage peristaltic pump i) carrying out OMD for about 4-6 hrs till the extract was concentrated in the feed tank.
PCT/IB2003/006105 2003-12-22 2003-12-22 An athermal process for the concentration of garcinia extract WO2005070863A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2005514334A JP4499664B2 (en) 2003-12-22 2003-12-22 Non-thermal treatment method for concentrating Garcinia extract
PCT/IB2003/006105 WO2005070863A1 (en) 2003-12-22 2003-12-22 An athermal process for the concentration of garcinia extract
AU2003288610A AU2003288610B2 (en) 2003-12-22 2003-12-22 An athermal process for the concentration of Garcinia extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2003/006105 WO2005070863A1 (en) 2003-12-22 2003-12-22 An athermal process for the concentration of garcinia extract

Publications (1)

Publication Number Publication Date
WO2005070863A1 true WO2005070863A1 (en) 2005-08-04

Family

ID=34803647

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/006105 WO2005070863A1 (en) 2003-12-22 2003-12-22 An athermal process for the concentration of garcinia extract

Country Status (3)

Country Link
JP (1) JP4499664B2 (en)
AU (1) AU2003288610B2 (en)
WO (1) WO2005070863A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109107223B (en) * 2018-10-15 2021-04-13 潘仲巍 Device and method for enriching ferulic acid from angelica sinensis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005741A1 (en) * 1994-08-24 1996-02-29 Renaissance Herbs, Inc. Hydroxycitric acid concentrate and method of making
WO2000015051A1 (en) * 1998-09-14 2000-03-23 Interhealth Nutraceuticals, Inc. Hydroxycitric acid compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005741A1 (en) * 1994-08-24 1996-02-29 Renaissance Herbs, Inc. Hydroxycitric acid concentrate and method of making
WO2000015051A1 (en) * 1998-09-14 2000-03-23 Interhealth Nutraceuticals, Inc. Hydroxycitric acid compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
B.S. JENA ET AL, J. AGRIC. FOOD CHEM., vol. 50, no. 12, 2002, pages 3431 - 3434, XP002279538 *
P.A. HOGAN ET AL, CHEMICAL ENGINEERING PROGRESS, vol. 94, no. 7, 1998, pages 49 - 61, XP000768656 *

Also Published As

Publication number Publication date
JP4499664B2 (en) 2010-07-07
JP2007527359A (en) 2007-09-27
AU2003288610A1 (en) 2005-08-11
AU2003288610B2 (en) 2010-06-17

Similar Documents

Publication Publication Date Title
Conidi et al. Valorization of artichoke wastewaters by integrated membrane process
US8728545B2 (en) Extraction method for providing an organic certifiable Stevia rebaudiana extract
EP1980569A1 (en) Process for preparing high purity corosolic acid and high purity ursolic acid
JPH07500127A (en) Antioxidant oleoresin composition and method for producing the same
EP1444177A1 (en) Extraction of phenolic antioxidants
JP3808494B2 (en) Method for producing high content of proanthocyanidins
KR101404286B1 (en) Method for preparing the extract fortified with chalcones from by-product of Angelica keiskei juice
EP3042573B1 (en) Chlorogenic-acid-containing composition, method for manufacturing same, and drink or food item
AU2003288610B2 (en) An athermal process for the concentration of Garcinia extract
US7431951B2 (en) Athermal process for the concentration of Garcinia extract
CN100581535C (en) Method for extracting and purifying flavonoids from apple powder agent and application thereof
WO2013190389A2 (en) Malic acid-enriched plant extract
AU2003226621B2 (en) A process for the encapsulation of garcinia extract
JP2001335716A (en) Deoderized safflower yellow coloring matter
US9822091B2 (en) Method for producing ellagic acid composition
CN101810317B (en) Preparation method of canophyllic polyphenol and application thereof
CN106188221A (en) Tiger ear Jinsui River soluble plant activity selenium polypeptide extract and extracting method thereof
CN1537478A (en) Health-care instant purpleblow maple granule preparaction , and its prepn. method
WO2006112496A1 (en) Method of producing proanthocyanidin-containing material
JP2019156746A (en) Production method of triterpenoid high content seed extract and triterpenoid high content seed extract
JP6142236B2 (en) Method for obtaining a desalted sugar alcohol concentrate extract from a halophyte
JP2002047432A (en) Purified purple corn coloring matter
KR101807547B1 (en) Method of highly efficiently extracting active ingredient from plant
CN117562939A (en) Sweet osmanthus standard active substance PHEG50 and preparation method and application thereof
AU2002351530A1 (en) Extraction of Phenolic antioxidants

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 391/DELNP/2004

Country of ref document: IN

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005514334

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003288610

Country of ref document: AU

122 Ep: pct application non-entry in european phase